State Street Corp Guardant Health, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Guardant Health, Inc. stock. As of the latest transaction made, State Street Corp holds 2,794,375 shares of GH stock, worth $85.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,794,375

Previous 2,754,977 1.43%

Holding current value

$85.7 Million

Previous $79.6 Million 19.47%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$22.3 - $36.29 $878,575 - $1.43 Million	39,398 Added 1.43%	2,794,375 $64.1 Million
Q2 2024 Aug 14, 2024	BUY	$16.07 - $31.84 $2.04 Million - $4.04 Million	126,940 Added 4.83%	2,754,977 $79.6 Million
Q1 2024 May 15, 2024	BUY	$17.13 - $26.91 $954,363 - $1.5 Million	55,713 Added 2.17%	2,628,037 $54.2 Million
Q4 2023 Feb 14, 2024	BUY	$21.58 - $29.5 $3.35 Million - $4.58 Million	155,177 Added 6.42%	2,572,324 $69.6 Million
Q3 2023 Nov 14, 2023	BUY	$25.8 - $39.97 $1.75 Million - $2.71 Million	67,890 Added 2.89%	2,417,147 $71.6 Million
Q2 2023 Aug 14, 2023	BUY	$20.94 - $38.01 $16.2 Million - $29.5 Million	775,806 Added 49.31%	2,349,257 $84.1 Million
Q1 2023 May 15, 2023	BUY	$22.92 - $33.76 $1.97 Million - $2.9 Million	85,956 Added 5.78%	1,573,451 $36.9 Million
Q4 2022 Feb 14, 2023	SELL	$25.44 - $59.78 $419,607 - $986,011	-16,494 Reduced 1.1%	1,487,495 $40.5 Million
Q3 2022 Nov 15, 2022	BUY	$43.66 - $61.0 $1.94 Million - $2.71 Million	44,483 Added 3.05%	1,503,989 $81 Million
Q2 2022 Aug 15, 2022	BUY	$28.82 - $77.35 $2.03 Million - $5.44 Million	70,336 Added 5.06%	1,459,506 $58.9 Million
Q1 2022 May 16, 2022	BUY	$48.25 - $100.49 $2.84 Million - $5.92 Million	58,867 Added 4.43%	1,389,170 $92 Million
Q4 2021 Feb 14, 2022	BUY	$88.71 - $120.43 $1.63 Million - $2.22 Million	18,417 Added 1.4%	1,330,303 $133 Million
Q3 2021 Nov 15, 2021	BUY	$98.77 - $132.17 $4.78 Million - $6.39 Million	48,365 Added 3.83%	1,311,886 $164 Million
Q2 2021 Aug 16, 2021	BUY	$109.77 - $165.68 $29.6 Million - $44.6 Million	269,276 Added 27.08%	1,263,521 $157 Million
Q1 2021 May 17, 2021	BUY	$127.04 - $179.1 $1.28 Million - $1.8 Million	10,062 Added 1.02%	994,245 $152 Million
Q4 2020 Feb 16, 2021	BUY	$99.96 - $135.93 $11.5 Million - $15.6 Million	114,552 Added 13.17%	984,183 $127 Million
Q3 2020 Nov 10, 2020	BUY	$80.32 - $111.8 $2.94 Million - $4.09 Million	36,587 Added 4.39%	869,631 $97.2 Million
Q2 2020 Aug 14, 2020	BUY	$60.49 - $97.5 $20.2 Million - $32.5 Million	333,792 Added 66.86%	833,044 $67.6 Million
Q1 2020 May 11, 2020	BUY	$59.04 - $88.81 $29.5 Million - $44.3 Million	499,252 New	499,252 $34.7 Million

Others Institutions Holding GH

# of Institutions

323

Shares Held

127M

Call Options Held

844K

Put Options Held

2.38M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.14B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Guardant Health, Inc. Transaction History